Cancer Vaccines
Researchers from National Institutes of Health describe findings in cancer vaccines
Published in Vaccine Weekly, September 10th, 2008
Current study results from the report, 'Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant,' have been published. "We have previously reported on the safety and immunologic response of a poxvirus-based vaccine encoding prostate-specific antigen (PSA) used in combination with radiation therapy in patients with localized prostate cancer. We hypothesized that a 'metronomic' dose of interleukin 2 (IL-2) as a biological adjuvant would cause less toxicity while maintaining immunologic response," scientists writing in the journal Clinical Cancer Research...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-09-10)
More Articles from Vaccine Weekly
- Johns Hopkins Medical Institutions
Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs - DNA Vaccines
Data on DNA vaccines described by F.S. Kano et al - Foot and Mouth Disease
Reports outline foot and mouth disease research from S. Parida and colleagues - Hepatitis C Virus
Research from Z.Y. Keck and co-authors yields new data on hepatitis C virus - Hepatitis C Virus
Research reports from Z.Y. Keck and co-authors provide new insights into hepatitis C virus - Immunization
Researchers from ALK-Abello S.A. publish findings in immunization - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
